10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

Form 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended June 30, 2013

OR

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from                      to

Commission file number     000-54319

LIFELOC TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Colorado	84-1053680
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)

12441 West 49th Ave., Unit 4

Wheat Ridge, Colorado  80033

(Address of principal executive offices)

(303) 431-9500

(Registrant’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes     o     No     x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x       No   o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer   o	Accelerated filer
Non-accelerated filer   o	Smaller reporting company   x
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes     o     No     x

Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:

Common Stock, no par value	2,432,416 Shares
(Class)	(outstanding at August 7, 2013)

LIFELOC TECHNOLOGIES, INC.

FORM 10-Q

For the Three Months Ended June 30, 2013

INDEX

				Page
				Number
PART I.      FINANCIAL INFORMATION				3
	ITEM 1		FINANCIAL STATEMENTS (UNAUDITED)
		-	Condensed Balance Sheets as of June 30, 2013 (Unaudited) and December 31, 2012	3
		-	Condensed Statements of Income (Unaudited) for the three months ended June 30, 2013 and 2012	4
		-	Condensed Statements of Income (Unaudited) for the six months ended June 30, 2013 and 2012	5
		-	Condensed Statements of Cash Flows (Unaudited) for the six months ended June 30, 2013 and 2012	6
		-	Notes to Condensed Financial Statements (Unaudited)	7
	ITEM 2		MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	10
	ITEM 4		CONTROLS AND PROCEDURES	13
PART II.     OTHER INFORMATION				14
	ITEM 6		EXHIBITS	14
SIGNATURE				15

2

PART IFINANCIAL INFORMATION

ITEM 1 – FINANCIAL STATEMENTS

LIFELOC TECHNOLOGIES, INC.

Condensed Balance Sheets

ASSETS
	June 30,
	2013			December 31,
CURRENT ASSETS:	(Unaudited)			2012
Cash	$	2,502,693		$	2,338,012
Accounts receivable, net		798,788			405,321
Installment receivables		1,032			-
Inventories, net		1,008,593			832,670
Income taxes receivable		20,041			174,129
Deferred taxes		153,850			130,172
Prepaid expenses and other		80,170			31,529
Total current assets		4,565,167			3,911,833
PROPERTY AND EQUIPMENT, at cost:
Production equipment		272,075			258,703
Office equipment		149,852			144,202
Sales and marketing equipment		177,701			175,344
Purchased software		46,203			46,203
Less accumulated depreciation		(431,714	)		(365,728	)
Total property and equipment, net		214,117			258,724
OTHER ASSETS:
Technology licenses, net		23,331			55,139
Patents, net		15,699			11,953
Deferred taxes, long term		6,638			2,112
Deposits and other		56,040			54,704
Total other assets		101,708			123,908
Total assets	$	4,880,992		$	4,294,465
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable	$	295,816		$	82,796
Customer deposits		510			294
Accrued expenses		247,407			278,324
Deferred income, current portion		218,613			158,527
Reserve for warranty expense		24,600			23,100
Total current liabilities		786,946			543,041
DEFERRED INCOME, net of current portion		17,467			5,559
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Common stock, no par value; 50,000,000 shares
authorized, 2,432,416 shares outstanding (2,422,416
at December 31, 2012)		4,324,897			4,309,697
Accumulated (deficit)		(248,318	)		(563,832	)
Total stockholders' equity		4,076,579			3,745,865
Total liabilities and stockholders'  equity	$	4,880,992		$	4,294,465

See accompanying notes

3

LIFELOC TECHNOLOGIES, INC.

Condensed Statements of Income (Unaudited)

	Three Months Ended June 30,
	2013			2012
REVENUES:
Product sales	$	1,986,662		$	1,537,861
Royalties		122,387			116,576
Total		2,109,049			1,654,437
COST OF SALES		1,055,129			852,729
GROSS PROFIT		1,053,920			801,708
OPERATING EXPENSES:
Research and development		263,700			113,498
Sales and marketing		274,516			214,429
General and administrative		282,464			276,332
Total		820,680			604,259
OPERATING INCOME		233,240			197,449
OTHER INCOME (EXPENSE):
Interest income		3,959			4,003
Bad debt recovery		2,000			6,000
Total		5,959			10,003
NET INCOME BEFORE PROVISION FOR TAXES		239,199			207,452
PROVISION FOR FEDERAL AND STATE INCOME TAXES		(65,694	)		(75,017	)
NET INCOME	$	173,505		$	132,435
NET INCOME PER SHARE, BASIC	$	0.07		$	0.05
NET INCOME PER SHARE, DILUTED	$	0.07		$	0.05
WEIGHTED AVERAGE SHARES, BASIC		2,426,542			2,422,416
WEIGHTED AVERAGE SHARES, DILUTED		2,426,542			2,445,416

See accompanying notes

4

LIFELOC TECHNOLOGIES, INC.

Condensed Statements of Income (Unaudited)

	Six Months Ended June 30,
	2013			2012
REVENUES:
Sales	$	3,764,586		$	3,341,550
Royalties		252,812			116,576
Total		4,017,398			3,458,126
COST OF SALES		2,014,308			1,853,020
GROSS PROFIT		2,003,090			1,605,106
OPERATING EXPENSES:
Research and development		424,269			232,829
Sales and marketing		522,843			414,447
General and administrative		620,445			582,916
Total		1,567,557			1,230,192
OPERATING INCOME		435,533			374,914
OTHER INCOME (EXPENSE):
Interest income		7,622			7,687
Bad debt recovery		5,000			6,000
Total		12,622			13,687
NET INCOME BEFORE PROVISION FOR TAXES		448,155			388,601
PROVISION FOR FEDERAL AND STATE INCOME TAXES		(132,641	)		(136,458	)
NET INCOME	$	315,514		$	252,143
NET INCOME PER SHARE, BASIC	$	0.13		$	0.10
NET INCOME PER SHARE, DILUTED	$	0.13		$	0.10
WEIGHTED AVERAGE SHARES, BASIC		2,430,537			2,422,416
WEIGHTED AVERAGE SHARES, DILUTED		2,430,537			2,445,416

See accompanying notes

5

LIFELOC TECHNOLOGIES, INC.

Condensed Statements of Cash Flows (Unaudited)

	Six Months Ended June 30,
CASH FLOWS FROM OPERATING ACTIVITIES:	2013			2012
Net income	$	315,514		$	252,143
Adjustments to reconcile net income to net cash
provided by operating activities-
Depreciation and amortization		98,507			83,970
Deferred taxes		(28,204	)		(46,433	)
Reserve for warranty expense		1,500			800
Changes in operating assets and liabilities-
Accounts receivable		(393,467	)		(56,932	)
Installment receivables		(1,032	)		-
Inventories		(175,923	)		129,906
Income taxes receivable		154,088			-
Prepaid expenses and other		(48,641	)		(42,130	)
Deposits and other		(1,336	)		2,099
Accounts payable		213,020			94,809
Customer deposits		216			2,091
Accrued expenses		(30,917	)		(233,216	)
Deferred income		71,994			107,287
Income taxes payable		-			56,697
Net cash provided from
operating activities		175,319			351,091
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment		(21,379	)		(67,550	)
Purchase of patent		(4,459	)		-
Net cash (used in) investing activities		(25,838	)		(67,550	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of 10,000 shares of common stock at $1.52 per share		15,200			-
NET INCREASE IN CASH		164,681			283,541
CASH, BEGINNING OF PERIOD		2,338,012			1,844,802
CASH, END OF PERIOD	$	2,502,693		$	2,128,343
Supplemental cash flow disclosure:
Cash paid for income taxes	$	1,790		$	133,694

See accompanying notes

6

LIFELOC TECHNOLOGIES, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

1.  ORGANIZATION AND NATURE OF BUSINESS

Lifeloc Technologies, Inc. (“Lifeloc” or the “Company”) is a Colorado based developer, manufacturer and marketer of portable hand-held breathalyzers and related supplies and education.  We design, produce and sell fuel-cell based breath alcohol testing equipment.  We compete in all major segments of the portable breath alcohol testing instrument market, including law enforcement, workplace, corrections, original equipment manufacturing (“OEM”) and consumer markets. In addition, we offer a line of supplies, accessories, services, and training to support customers’ alcohol testing programs. We sell globally through distributors and sales agents, as well as directly to users.

2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

These financial statements have been prepared by us, without audit, and reflect normal recurring adjustments which, in the opinion of management, are necessary for a fair statement of the results of the second quarter of 2013.  These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with footnotes contained in our financial statements for the year ended December 31, 2012 included in our Form 10-K.

Use of Estimates in the Preparation of Financial Statements.   The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities of the Company as well as disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expense during the reporting period.  Actual results could differ from those estimates.

Note Receivable. We made a loan of $62,500 to Tipping Point, Inc. (“TPI”), an early stage company, during the second quarter of 2011.  Although the loan has been paid down by $27,000, including a repayment of $2,000 in the second quarter of 2013, we do not expect to realize any significant sales to TPI in the near term.  We have provided a reserve against the loan for the full amount, leaving a net amount of $0, which is not included in our balance sheet at June 30, 2013.  This note has a provision entitling us to convert any outstanding balance into stock of TPI.  TPI is considered a related party as certain of our board members were also TPI board members during a portion of 2011.

Inventories.   Inventories are stated at the lower of cost (first-in, first-out basis) or market. We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required.  At June 30, 2013 and December 31, 2012, inventory consisted of the following:

	2013			2012
Raw materials & deposits	$	415,647		$	271,865
Work-in-process		198,140			126,209
Finished goods		451,370			479,596
Total gross inventories		1,065,157			877,670
Less reserve for obsolescence		(56,564	)		(45,000	)
Total net inventories	$	1,008,593		$	832,670

Income Taxes.  We account for income taxes under the provisions of Accounting Standards Codification Topic 740, “Accounting for Income Taxes” (“ASC 740”). We have determined an estimated annual effective tax rate.  The rate will be revised, if necessary, as of the end of each successive interim period during our fiscal year to our best current estimate.

The estimated annual effective tax rate is applied to the year-to-date ordinary income (or loss) at the end of the interim period.

ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  This pronouncement also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

Revenue Recognition.   Revenue from product sales is recorded when we ship the product and title has passed to the customer, provided that we have evidence of a customer arrangement and can conclude that collection is probable.  The prices at which we sell our products are fixed and determinable at the time we accept a customer's order. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims, and generally have no ongoing obligations related to product sales, except for normal warranty.

Deferred revenues arising from installment receivables are recognized as sales when collected.  Service contracts are booked as sales over their life on a straight-line basis; development contracts are considered as sales when they are complete.  Supplies are recognized as sales when they are shipped.  Training revenues are recognized at the time the training occurs.  On occasion we arrange for customer financing and leasing through unrelated third parties.  We recognize as revenue a fee from this arrangement at the time of the transaction.  Occasionally, we rent used breathalyzers to customers, and in those cases, we recognize the revenues as they are earned over the life of the contract. 

7

Royalty income is recognized in accordance with agreed upon terms, when performance obligations are satisfied, the amount is fixed or determinable and collectability is reasonably assured.

Deferred Revenue.  Deferred revenues arise from installment receivables, from service contracts and from development contracts.   Deferred revenues from installment receivables are recognized as sales when collected, generally over two years.  Revenues from service contracts are recognized on a straight-line basis over the life of the contract, generally one year.  However, there are occasions when they are written for longer terms up to four years.  The revenues from that portion of the contract that extend beyond one year and from that portion of installment receivables that extend beyond one year are shown in our balance sheet as long term.  Deferred revenues also result from progress payments received on development contracts; those revenues are recognized when the contract is complete.  All development contracts are for less than one year and all deferred revenues from this source are shown in our balance sheet as short term.

Fair Value of Financial Instruments.   Our financial instruments consist of cash and cash equivalents, short-term trade receivables, short-term installment receivables, note receivable and payables.  The carrying values of cash and cash equivalents, short-term receivables and payables approximate their fair value due to their short term maturities.

Recent Accounting Pronouncements.  We have reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial condition or the results of our operations.

3.  BASIC AND DILUTED INCOME PER COMMON SHARE

We report both basic and diluted net income per share.  Basic net income per common share is computed by dividing net income or loss for the period by the weighted average number of common shares outstanding for the period.  Diluted net income or loss per common share is computed by dividing the net income for the period by the weighted average number of common and potential common shares outstanding during the period if the effect of the potential common shares is dilutive.  The shares used in the calculation of dilutive potential common shares exclude options to purchase shares where the exercise price was greater than the average market price of common shares for the period.

The following table presents the calculation of basic and diluted net income (loss) per share:

	Three Months Ended
	June 30, 2013		June 30, 2012
Net income	$	173,505	$	132,435
Weighted-average shares — basic		2,426,542		2,422,416
Effect of dilutive potential common shares		-		23,000
Weighted-average shares — diluted		2,426,542		2,445,416
Net income per share — basic	$	0.07	$	0.05
Net income per share — diluted	$	0.07	$	0.05
Antidilutive employee stock options		-		-

	Six Months Ended
	June 30, 2013		June 30, 2012
Net income	$	315,514	$	252,143
Weighted-average shares — basic		2,430,537		2,422,416
Effect of dilutive potential common shares		-		23,000
Weighted-average shares — diluted		2,430,537		2,445,416
Net income per share — basic	$	0.13	$	0.10
Net income per share — diluted	$	0.13	$	0.10
Antidilutive employee stock options		-		-

4.  STOCKHOLDERS’ EQUITY

The following table summarizes information about employee stock options outstanding and exercisable at June 30, 2013:

	STOCK OPTIONS OUTSTANDING				STOCK OPTIONS EXERCISABLE
Range of Exercise Prices	Number Outstanding	Weighted-Average Remaining Contractual Life (in Years)	Weighted-Average Exercise Price  per Share		Number  Exercisable	Weighted-Average Exercise Price  per Share
$3.69	23,000	4		$3.69	23,000		$3.69

8

Of the 23,000 options exercisable as of June 30, 2013, all are incentive stock options. The exercise price of all options granted through June 30, 2013 has been equal to or greater than the fair market value.

On April 1, 2013 our shareholders approved the adoption of a stock option plan providing for the grant of stock options to purchase up to 150,000 shares of our common stock.  None of these options had been granted as of June 30, 2013.

The total number of authorized shares of common stock continues to be 50,000,000, with no change in the par value per share.

5.  RELATED PARTY TRANSACTIONS

During the six months ended June 30, 2013, we paid a consulting fee of $15,000 to a director.  No consulting fee was paid during the six months ended June 30, 2012.

6.  LINE OF CREDIT

Our line of credit for $150,000 with Citywide Bank matured on June 1, 2013, and was not renewed.  There was no balance due on the line of credit as of June 30, 2013.

7.  COMMITMENTS

We entered into a development contract in March 2013, which calls for an initial deposit of $31,602, followed by payments totaling $94,804 to be made as work is performed.

8.  SUBSEQUENT EVENTS

We evaluated all of our activity and concluded that no subsequent events have occurred that would require recognition in our financial statements or disclosure in the notes to our financial statements.

9

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following is a discussion of our financial condition and results of operations, and should be read in conjunction with our financial statements and the related notes included elsewhere in this Form 10-Q.  Certain statements contained in this section are not historical facts, including statements about our strategies and expectations about new and existing products, market demand, acceptance of new and existing products, technologies and opportunities, market and industry segment growth, and return on investments in products and markets.  These statements are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), and we intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in these statutes.  You can identify forward-looking statements by the use of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans” or “anticipates” or the negative of these words and phrases or similar words or phrases that are predictions of or indicate future events or trends and that do not relate solely to historical matters.  Such statements involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements.  All forward-looking statements in this section are based on information available to us on the date of this document, and we assume no obligation to update such forward looking statements.  Readers of this Form 10-Q are strongly encouraged to review the section titled “Risk Factors” in our December 31, 2012 Form 10-K.

Overview

We have been a developer and manufacturer of advanced alcohol testing instruments since 1986.  We design and produce high-quality, precise and rapid recovery alcohol testing instruments for use in workplace, clinics, schools, law enforcement, corrections, and other applications.  We offer our customers accessories, service support, training and supplies.   Our internet websites are www.lifeloc.com and www.lifeguardbreathtester.com.

On July 24, 2013, we announced the launch of a new product, the Sentinel breath alcohol access control system, an automated monitoring system that performs high volume "zero tolerance" screening of employees, visitors or contractors in safety sensitive industries such as mining, construction, and oil and gas.

The areas in which we do business are highly competitive and include both foreign and domestic competitors.  Our major competitors are larger and have substantially greater resources than we do. Furthermore, other domestic or foreign companies, some with greater financial resources than we have, may seek to produce products or services that compete with ours.

We believe that competition for sales of alcohol testing products is based on product performance, service, delivery and price.

We believe that our future success depends to a large degree on our ability to develop new alcohol testing products and services to enhance the performance characteristics and methods of manufacture of existing products.  Accordingly, we expect to continue to invest resources in research and development, to the extent funds are available.

Results of Operations

For the three months ended June 30, 2013 compared to the three months ended June 30, 2012.

Net sales. Our product sales for the quarter ended June 30, 2013 were $1,986,662, an increase of 29% from $1,537,861 for the quarter ended June 30, 2012.  This increase is attributable to an increase in orders from all customers, offset in part by a decrease in orders from a large customer redesigning its ignition interlock product and therefore placing fewer orders.  When royalties of $122,387 are included, total revenues of $2,109,049 increased by $454,612, or 28%, for the quarter ended June 30, 2013 when compared to the same quarter a year ago.

Gross profit.  Gross profit for the quarter ended June 30, 2013 of $1,053,920 represented an increase of 32% from gross profit of $801,708 for the quarter ended June 30, 2012 as a result of the higher sales volume discussed above.  Gross profit as a percentage of product sales increased from 52% to 53% as a result of a different product mix for the quarter ended June 30, 2013 versus the product mix for the quarter ended June 30, 2012.

Research and development expenses.  Research and development expenses were $263,700 for the quarter ended June 30, 2013, representing an increase of 132% over the $113,498 in the same quarter a year ago.  This increase resulted from personnel and compensation increases, and from payments to outside vendors, required to maintain our product development efforts.

Sales and marketing expenses.   Sales and marketing expenses of $274,516 for the quarter ended June 30, 2013 represented an increase of 28% from sales and marketing expenses of $214,429 for the quarter ended June 30, 2012.  This increase resulted primarily from increased advertising outlays, from increased commissions as a result of increased sales volume, and from increased compensation.

General and administrative expenses.   General and administrative expenses were $282,464 for the quarter ended June 30, 2013, which represented an increase of 2% over the $276,332 spent in the same quarter a year ago.  This increase results mostly from additional compensation expense.

Other income.  The decrease in other income resulted primarily from a lower recovery of principal from a loan to Tipping Point, Inc. (“TPI”), an early stage company, in the quarter ended June 30, 2013.

10

Net income.   Net income was $173,505 for the quarter ended June 30, 2013 compared to net income of $132,435 for the quarter ended June 30, 2012.  This increase of $41,070, or 31%, was the result of an increase in gross profit, offset in part by increased operating expenses as described above, and from a decrease in the provision for federal and state income taxes of $9,323.

For the six months ended June 30, 2013 compared to the six months ended June 30, 2012.

Net sales. Our product sales for the six months ended June 30, 2013 were $3,764,586, an increase of 13% from $3,341,550  for the six months ended June 30, 2012.  This increase is attributable to an increase in orders from all customers, offset in part by a decrease in orders from a large customer redesigning its ignition interlock product and therefore placing fewer orders.  When royalties of $252,812 are included, total revenues of $4,017,398 increased by $559,272, or 16%, for the six months ended June 30, 2013 when compared to the same six months a year ago.

Gross profit.  Gross profit for the six months ended June 30, 2012 of $2,003,090 represented an increase of 25% from gross profit of $1,605,106 for the six months ended June 30, 2012.  Gross profit as a percentage of sales (gross margins) increased from 48% to 53% as a result of a different product mix as well as economies of scale for the six months ended June 30, 2013 vs. the six months ended June 30, 2012.

Research and development expenses.  Research and development expenses were $424,269 for the six months ended June 30, 2013, representing an increase of 82% over the $232,829 in the same six month period a year ago.  This increase resulted from personnel and compensation increases, and from payments to outside vendors, required to maintain our product development efforts.

Sales and marketing expenses.   Sales and marketing expenses of $522,843 for the six months ended June 30, 2013 represented an increase of 26% from sales and marketing expenses of $414,447 for the six months ended June 30, 2012.  This increase resulted primarily from increased advertising outlays, from increased commissions as a result of increased sales volume, and from increased compensation.

General and administrative expenses.   General and administrative expenses were $620,445 for the six months ended June 30, 2013, which represented an increase of 6% over the $582,916 spent in the same six month period a year earlier.  This increase results mostly from additional compensation.

Net income.   Net income was $315,514 for the six months ended June 30, 2013 compared to net income of $252,143 for the six months ended June 30, 2012.  This increase of $63,371, or 25%, was the result of an increase in gross profit, offset in part by increased operating expenses as described above, and from a decreased provision for federal and state income taxes of $3,817.

Trends and Uncertainties That May Affect Future Results

We expect our quarter-to-quarter revenue fluctuations to continue, due to the unpredictable timing of large orders from customers and the size of those orders in relation to total revenues.  Going forward, we intend to focus our development efforts on products we believe offer the best prospects to increase our intermediate and near-term revenues.

Our 2013 operating plan is focused on growing sales, increasing gross profits, increasing research and development costs as appropriate while increasing profits and positive cash flows.  We cannot predict with certainty the expected sales, gross profit, net income or loss and usage of cash and cash equivalents for 2013.  However, we believe that cash resources and borrowing capacity will be sufficient to fund our operations for the next twelve months under our current operating plan.  If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional capital may be required to maintain ongoing operations.

Liquidity and Capital Resources

We compete in a highly technical, very competitive and, in most cases, price driven alcohol testing marketplace, where products can take years to develop and introduce to distributors and end users.  Furthermore, manufacturing, marketing and distribution activities are regulated by the FDA, the DOT, and other regulatory bodies that, while intended to enhance the ultimate quality and functionality of products produced, can contribute to the cost and time needed to maintain existing products and develop and introduce new products.

We have traditionally funded working capital needs through product sales and close management of working capital components of our business.  Historically, we have also received cash from private offerings of our common stock, warrants to purchase shares of our common stock, and notes. In our earlier years, we incurred quarter to quarter operating losses to develop current product applications, utilizing a number of proprietary and patent-pending technologies.  Although we have been profitable during the last several years, we expect that operating losses could well occur in the future.  Should that situation arise, we may not be able to obtain working capital funds necessary in the time frame needed and at satisfactory terms or at all.

On June 1, 2013, our credit facility agreement with Citywide Bank, matured and was not renewed.  The terms of the credit facility included a line of credit for $150,000 at an interest rate calculated at prime rate plus 1%.  At June 1, 2013, we had not borrowed any amounts from the credit facility.  

11

As of June 30, 2013, cash was $2,502,693, trade accounts receivable, including installment receivables, were $799,820 and current liabilities were $786,946 resulting in a net liquid asset amount of $2,514,535.  We believe that the introduction of several new products during the last several years, along with new and on-going customer relationships, will continue to generate sufficient revenues to maintain profitability.  If these revenues are not achieved on a timely basis, we will be required to implement cost reduction measures, as necessary.

We made a loan of $62,500 to TPI, an early stage company, during Q2 of 2011.  Although the loan has been paid down by $27,000, including a repayment of $2,000 in the second quarter of 2013, we do not expect to realize any significant sales to TPI in the near term.  We have provided a reserve against the full amount of the loan, leaving a net amount of $0, which is not included in our balance sheet at June 30, 2013.  Two of our directors formerly served as directors of TPI.

We generally provide a standard one-year warranty on materials and workmanship to our customers.  We provide for estimated warranty costs at the time product revenue is recognized.  Warranty costs are included as a component of cost of goods sold in the accompanying statements of operations.  For the quarter ended June 30, 2013 and for the quarter ended June 30, 2012, warranty costs were not deemed significant.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, sales and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to bad debts, inventories, sales returns, warranty, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe the following critical accounting policies affect the more significant judgments and estimates used in the preparation of our financial statements.

We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances would be required, which would increase our expenses during the periods in which any such allowances were made. The amount recorded as an allowance for bad debts in each period is based upon our assessment of the likelihood that we will be paid on our outstanding receivables, based on customer-specific as well as general considerations. To the extent that our estimates prove to be too high, and we ultimately collect a receivable previously determined to be impaired, we may record a reversal of the provision in the period of such determination.

We provide for the estimated cost of product warranties at the time sales are recognized. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers, we have experienced some costs related to warranties. The warranty accrual is based on historical experience and is adjusted based on current experience. Should actual warranty experience differ from our estimates, revisions to the estimated warranty liability would be required.

We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based on assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. Any write-downs of inventory would reduce our reported net income during the period in which such write-downs were applied. To the extent that our estimates prove to be too high, and we ultimately utilize or sell inventory previously determined to be impaired, we may record a reversal of the provision in the period of such determination.

We recognize deferred income tax assets and liabilities for the expected future income tax consequences, based on enacted tax laws, of temporary differences between the financial reporting and tax bases of assets and liabilities. Deferred tax assets are then reduced, if deemed necessary, by a valuation allowance for the amount of any tax benefits which, more likely than not based on current circumstances, are not expected to be realized. Should we maintain sufficient, sustained income in the future, we may conclude that all or some of the valuation allowance should be reversed.

Property and equipment are stated at cost, with depreciation computed over the estimated useful lives of the assets, generally three to five years. We use the double declining method of depreciation for property and equipment.   Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life of the asset. Maintenance and repairs are expensed as incurred and major additions, replacements and improvements are capitalized.

We amortize our patent costs over their estimated useful lives, which is typically the remaining statutory life. From time to time, we may be required to adjust these useful lives of our patents based on advances in technology, competitor actions, and the like. We review the recorded amounts of patents at each period end to determine if their carrying amount is still recoverable based on our expectations regarding sales of related products. Such an assessment, in the future, may result in a conclusion that the assets are impaired, with a corresponding charge against earnings.

12

We recognize revenue from product sales when we ship the product and title has passed to the customer, provided that we have evidence of a customer arrangement and can conclude that collection is probable.  The prices at which we sell our products are fixed and determinable at the time we accept a customer's order. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims, and generally have no ongoing obligations related to product sales, except for normal warranty.

Royalty income is recognized in accordance with agreed upon terms, when performance obligations are satisfied, the amount is fixed or determinable and collectability is reasonably assured.

Deferred revenues arising from installment receivables are recognized as sales when collected.  Service contracts are booked as sales over their life on a straight-line basis, generally one to two years.  However, there are occasions when they are written for longer terms up to four years.  In those cases, the revenues from that portion of the contract that extend beyond one year are shown in our balance sheet as long term.  Deferred revenues also result from progress payments received on development contracts; those revenues are recognized when the contract is complete.  All development contracts are for less than one year and all deferred revenues from this source are shown in our balance sheet as short term.  On occasion we arrange for customer financing and leasing through unrelated third parties.  We recognize as revenue a fee from this arrangement at the time of the transaction.  During the quarter ended June 30, 2013, we adopted the policy of retaining such leases.  Occasionally, we rent used breathalyzers to customers, and in those cases, we recognize the revenues as they are earned over the life of the contract.  Supplies are recognized as sales when they are shipped.  Training revenues are recognized at the time the training occurs.

ITEM 4   –   CONTROLS AND PROCEDURES

Our Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Form 10-Q, have concluded that, based on such evaluation, our disclosure controls and procedures were not effective as of June 30, 2013 because of the material weaknesses in our internal control over financial reporting discussed below.

1.   Insufficient access to appropriate technical research materials and sufficient technical accounting knowledge within the accounting department related to accounting for complex transactions and to evolving generally accepted accounting principles.

2.   Insufficient technical accounting knowledge within the audit committee to adequately provide oversight of the Company’s accounting and reporting functions.

Because of the material weaknesses identified above, a reasonable possibility exists that a material misstatement in our financial statements will not be prevented or detected on a timely basis. However, our Chief Executive Officer and Principal Accounting Officer believe that the financial statements included in this quarterly report on Form 10-Q present, in all material respects, our financial position, results of operations and cash flows for the periods presented, in conformity with U.S. GAAP.

Remediation of Material Weaknesses

The remediation efforts outlined below are intended to address the identified material weaknesses in internal control over financial reporting.

1.   We have acquired access to additional technical research materials and have evaluated the need to retain additional personnel to enable our accounting department to adequately respond to changes in our operations and to changes within generally accepted accounting principles.

2.   We have appointed a new director to our audit committee with the required credentials to serve as our audit committee financial expert.

We will consider the results of our remediation efforts and related testing as part of our year-end 2013 assessment of the effectiveness of our internal control over financial reporting.

Changes in Internal Control over Financial Reporting

Except as otherwise noted above, there were no significant changes in our internal control over financial reporting during the period ended June 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the Effectiveness of Controls

A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met.  Our management, including our Chief Executive Officer and our Chief Financial Officer, do not expect that the Company’s disclosure controls will prevent or detect all errors and all fraud.  Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs.  Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.  These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple error or mistake.  Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls.  The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.  Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with associated policies or procedures.  Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

13

PART II. OTHER INFORMATION

ITEM 1 – LEGAL PROCEEDINGS

From time to time, we are subject to legal proceedings and claims that arise in the ordinary course of business. As of the date of this filing, there are no material pending or overtly threatened legal actions against us of which we are aware.

ITEM 1A – RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in ‘‘Risk Factors’’ in our Annual Report on Form 10-K for the year ended December 31, 2012, which could materially affect our business, financial condition and/or future results.  The risks described in our Annual Report on Form 10-K are not the only risks facing us.  Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the 3 months ended March 31, 2013 we sold 10,000 shares of common stock to an officer and director at $1.52 per share pursuant to the exemption from registration provided by Section 4(2) of the Securities Act of 1933, as amended. The full purchase price was paid in cash.

ITEM 6 – EXHIBITS

The following exhibits are filed with this report on Form 10-Q or are incorporated by reference:

Exhibit No.	Description of Exhibit
10.1	Lifeloc Technologies, Inc. Stock Option Plan (incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2013)
31.1	Certification of Principal Executive Officer Pursuant To Section 302 Of The Sarbanes—Oxley Act Of 2002
31.2	Certification of Principal Financial Officer Pursuant To Section 302 Of The Sarbanes—Oxley Act Of 2002
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101	Interactive Data Files Pursuant to Rule 405 of Regulation S-T.

14

SIGNATURE

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		LIFELOC TECHNOLOGIES, INC.
August 9, 2013	By:	/s/ Barry R. Knott
Date		Barry R. Knott
		President and Chief Executive Officer (Principal Executive Officer)
August 9, 2013	By:	/s/ Kristie L. LaRose
Date		Kristie L. LaRose
		Vice President of Finance and Administration (Principal Accounting Officer)

15

Exhibit Index

Exhibit No.	Description of Exhibit
10.1	Lifeloc Technologies, Inc. Stock Option Plan  (incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2013)
31.1	Certification of Principal Executive Officer Pursuant To Section 302 Of The Sarbanes—Oxley Act Of 2002
31.2	Certification of Principal Financial Officer Pursuant To Section 302 Of The Sarbanes—Oxley Act Of 2002
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101	Interactive Date Files Pursuant to Rule 405 of Regulation S-T.

(1)       Incorporated by reference to our Registration Statement on Form 10-12G, filed on March 31, 2011.

(2) Incorporated by reference to our Registration Statement on Form 10-12G (Amendment 1), filed on May 11, 2011.

16

EX-31.1

 Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Barry R. Knott, certify that:

1.               I have reviewed this report on Form 10-Q of Lifeloc Technologies, Inc.;

2.               Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.               Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.               The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)              designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)              designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)               evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)              disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.               The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)              all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting  which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)              any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  August 9, 2013

/s/ Barry R. Knott

Barry R. Knott

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Vern D. Kornelsen, certify that:

1.               I have reviewed this report on Form 10-Q of Lifeloc Technologies, Inc.;

2.               Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.               Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.               The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)              designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)              designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)               evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)              disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.               The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)              all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)              any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  August 9, 2013

/s/ Vern D. Kornelsen

Vern D. Kornelsen

Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Barry R. Knott, President and Chief Executive Officer of Lifeloc Technologies, Inc. (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

                   the Quarterly Report on Form 10-Q of the Company for the six months ended June 30, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

                   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by the Report.

Dated:  August 9, 2013

/s/ Barry R. Knott

Barry R. Knott

President and Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Vern D. Kornelsen, Chief Financial Officer of Lifeloc Technologies, Inc. (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

                   the Quarterly Report on Form 10-Q of the Company for the six months ended June 30, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

                   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by the Report.

Dated:  August 9, 2013

/s/ Vern D. Kornelsen

Vern D. Kornelsen

Chief Financial Officer

XML

4. STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Jun. 30, 2013

Stockholders Equity Tables

Stock options outstanding and exercisable

	STOCK OPTIONS OUTSTANDING				STOCK OPTIONS EXERCISABLE
Range of Exercise Prices	Number Outstanding	Weighted-Average Remaining Contractual Life (in Years)	Weighted-Average Exercise Price  per Share		Number  Exercisable	Weighted-Average Exercise Price  per Share
$3.69	23,000	4		$3.69	23,000		$3.69

XML

Condensed Statements of Income (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
REVENUES:
Product sales	$ 1,986,662	$ 1,537,861	$ 3,764,586	$ 3,341,550
Royalties	122,387	116,576	252,812	116,576
Total sales	2,109,049	1,654,437	4,017,398	3,458,126
COST OF SALES	1,055,129	852,729	2,014,308	1,853,020
GROSS PROFIT	1,053,920	801,708	2,003,090	1,605,106
OPERATING EXPENSES:
Research and development	263,700	113,498	424,269	232,829
Sales and marketing	274,516	214,429	522,843	414,447
General and administrative	282,464	276,332	620,445	582,916
Total	820,680	604,259	1,567,557	1,230,192
OPERATING INCOME	233,240	197,449	435,533	374,914
OTHER INCOME (EXPENSE):
Interest income	3,959	4,003	7,622	7,687
Bad debt recovery	2,000	6,000	5,000	6,000
Total	5,959	10,003	12,622	13,687
NET INCOME BEFORE PROVISION FOR TAXES	239,199	207,452	448,155	388,601
PROVISION FOR FEDERAL AND STATE INCOME TAXES	(65,694)	(75,017)	(132,641)	(136,458)
NET INCOME	$ 173,505	$ 132,435	$ 315,514	$ 252,143
NET INCOME PER SHARE, BASIC	$ 0.07	$ 0.05	$ 0.13	$ 0.1
NET INCOME PER SHARE, DILUTED	$ 0.07	$ 0.05	$ 0.13	$ 0.1
WEIGHTED AVERAGE SHARES, BASIC	2,426,542	2,422,416	2,430,537	2,422,416
WEIGHTED AVERAGE SHARES, DILUTED	2,426,542	2,445,416	2,430,537	2,445,416

XML

5. RELATED PARTY TRANSACTIONS

6 Months Ended

Jun. 30, 2013

Related Party Transactions [Abstract]

Note 5 - RELATED PARTY TRANSACTIONS

5.  RELATED PARTY TRANSACTIONS

During the six months ended June 30, 2013, we paid a consulting fee of $15,000 to a director.  No consulting fee was paid during the six months ended June 30, 2012.

XML

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Inventories
Raw materials & deposits	$ 415,647	$ 271,865
Work-in-process	198,140	126,209
Finished goods	451,370	479,596
Total gross inventories	1,065,157	877,670
Less reserve for obsolescence	(56,564)	(45,000)
Total net inventories	$ 1,008,593	$ 832,670

XML

1. ORGANIZATION AND NATURE OF BUSINESS

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements

NOTE 1 - ORGANIZATION AND NATURE OF BUSINESS

1.  ORGANIZATION AND NATURE OF BUSINESS

Lifeloc Technologies, Inc. (“Lifeloc” or the “Company”) is a Colorado based developer, manufacturer and marketer of portable hand-held breathalyzers and related supplies and education.  We design, produce and sell fuel-cell based breath alcohol testing equipment.  We compete in all major segments of the portable breath alcohol testing instrument market, including law enforcement, workplace, corrections, original equipment manufacturing (“OEM”) and consumer markets. In addition, we offer a line of supplies, accessories, services, and training to support customers’ alcohol testing programs. We sell globally through distributors and sales agents, as well as directly to users.

XML

3. BASIC AND DILUTED INCOME PER COMMON SHARE

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements

NOTE 3 - BASIC AND DILUTED INCOME PER COMMON SHARE

3.  BASIC AND DILUTED INCOME PER COMMON SHARE

We report both basic and diluted net income per share.  Basic net income per common share is computed by dividing net income or loss for the period by the weighted average number of common shares outstanding for the period.  Diluted net income or loss per common share is computed by dividing the net income for the period by the weighted average number of common and potential common shares outstanding during the period if the effect of the potential common shares is dilutive.  The shares used in the calculation of dilutive potential common shares exclude options to purchase shares where the exercise price was greater than the average market price of common shares for the period.

The following table presents the calculation of basic and diluted net income (loss) per share:

	Three Months Ended
	June 30, 2013		June 30, 2012
Net income	$	173,505	$	132,435
Weighted-average shares — basic		2,426,542		2,422,416
Effect of dilutive potential common shares		-		23,000
Weighted-average shares — diluted		2,426,542		2,445,416
Net income per share — basic	$	0.07	$	0.05
Net income per share — diluted	$	0.07	$	0.05
Antidilutive employee stock options		-		-

	Six Months Ended
	June 30, 2013		June 30, 2012
Net income	$	315,514	$	252,143
Weighted-average shares — basic		2,430,537		2,422,416
Effect of dilutive potential common shares		-		23,000
Weighted-average shares — diluted		2,430,537		2,445,416
Net income per share — basic	$	0.13	$	0.10
Net income per share — diluted	$	0.13	$	0.10
Antidilutive employee stock options		-		-

XML

6. LINE OF CREDIT

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements

NOTE 6 - LINE OF CREDIT

6.  LINE OF CREDIT

Our line of credit for $150,000 with Citywide Bank matured on June 1, 2013, and was not renewed.  There was no balance due on the line of credit as of June 30, 2013.

XML

4. STOCKHOLDERS' EQUITY

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements

NOTE 4 - STOCKHOLDERS' EQUITY

4.  STOCKHOLDERS’ EQUITY

The following table summarizes information about employee stock options outstanding and exercisable at June 30, 2013:

	STOCK OPTIONS OUTSTANDING				STOCK OPTIONS EXERCISABLE
Range of Exercise Prices	Number Outstanding	Weighted-Average Remaining Contractual Life (in Years)	Weighted-Average Exercise Price  per Share		Number  Exercisable	Weighted-Average Exercise Price  per Share
$3.69	23,000	4		$3.69	23,000		$3.69

Of the 23,000 options exercisable as of June 30, 2013, all are incentive stock options. The exercise price of all options granted through June 30, 2013 has been equal to or greater than the fair market value.

On April 1, 2013 our shareholders approved the adoption of a stock option plan providing for the grant of stock options to purchase up to 150,000 shares of our common stock.  None of these options had been granted as of June 30, 2013.

The total number of authorized shares of common stock continues to be 50,000,000, with no change in the par value per share.

XML

Condensed Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2013	Dec. 31, 2012
STOCKHOLDERS' EQUITY:
Common stock, par value	$ 0	$ 0
Common stock, authorized shares	50,000,000	50,000,000
Common stock, issued shares	2,422,416	2,422,416
Common stock, outstanding shares	2,422,416	2,422,416

XML

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Jun. 30, 2013

Summary Of Significant Accounting Policies Policies

Use of Estimates

Use of Estimates in the Preparation of Financial Statements.   The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities of the Company as well as disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expense during the reporting period.  Actual results could differ from those estimates.

Note Receivable

Note Receivable. We made a loan of $62,500 to Tipping Point, Inc. (“TPI”), an early stage company, during the second quarter of 2011.  Although the loan has been paid down by $27,000, including a repayment of $2,000 in the second quarter of 2013, we do not expect to realize any significant sales to TPI in the near term.  We have provided a reserve against the loan for the full amount, leaving a net amount of $0, which is not included in our balance sheet at June 30, 2013.  This note has a provision entitling us to convert any outstanding balance into stock of TPI.  TPI is considered a related party as certain of our board members were also TPI board members during a portion of 2011.

Inventories

Inventories.   Inventories are stated at the lower of cost (first-in, first-out basis) or market. We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required.  At June 30, 2013 and December 31, 2012, inventory consisted of the following:

	2013			2012
Raw materials & deposits	$	415,647		$	271,865
Work-in-process		198,140			126,209
Finished goods		451,370			479,596
Total gross inventories		1,065,157			877,670
Less reserve for obsolescence		(56,564	)		(45,000	)
Total net inventories	$	1,008,593		$	832,670

Income Taxes

Income Taxes.  We account for income taxes under the provisions of Accounting Standards Codification Topic 740, “Accounting for Income Taxes” (“ASC 740”). We have determined an estimated annual effective tax rate.  The rate will be revised, if necessary, as of the end of each successive interim period during our fiscal year to our best current estimate.

The estimated annual effective tax rate is applied to the year-to-date ordinary income (or loss) at the end of the interim period.

ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  This pronouncement also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

Revenue Recognition

Revenue Recognition.   Revenue from product sales is recorded when we ship the product and title has passed to the customer, provided that we have evidence of a customer arrangement and can conclude that collection is probable.  The prices at which we sell our products are fixed and determinable at the time we accept a customer's order. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims, and generally have no ongoing obligations related to product sales, except for normal warranty.

Deferred revenues arising from installment receivables are recognized as sales when collected.  Service contracts are booked as sales over their life on a straight-line basis; development contracts are considered as sales when they are complete.  Supplies are recognized as sales when they are shipped.  Training revenues are recognized at the time the training occurs.  On occasion we arrange for customer financing and leasing through unrelated third parties.  We recognize as revenue a fee from this arrangement at the time of the transaction.  Occasionally, we rent used breathalyzers to customers, and in those cases, we recognize the revenues as they are earned over the life of the contract. 

Royalty income is recognized in accordance with agreed upon terms, when performance obligations are satisfied, the amount is fixed or determinable and collectability is reasonably assured.

Deferred Revenue

Deferred Revenue.  Deferred revenues arise from installment receivables, from service contracts and from development contracts.   Deferred revenues from installment receivables are recognized as sales when collected, generally over two years.  Revenues from service contracts are recognized on a straight-line basis over the life of the contract, generally one year.  However, there are occasions when they are written for longer terms up to four years.  The revenues from that portion of the contract that extend beyond one year and from that portion of installment receivables that extend beyond one year are shown in our balance sheet as long term.  Deferred revenues also result from progress payments received on development contracts; those revenues are recognized when the contract is complete.  All development contracts are for less than one year and all deferred revenues from this source are shown in our balance sheet as short term.

Fair Value of Financial Instruments

Fair Value of Financial Instruments.   Our financial instruments consist of cash and cash equivalents, short-term trade receivables, short-term installment receivables, note receivable and payables.  The carrying values of cash and cash equivalents, short-term receivables and payables approximate their fair value due to their short term maturities.

Recent Accounting Pronouncements

Recent Accounting Pronouncements.  We have reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial condition or the results of our operations.

XML

Condensed Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 315,514	$ 252,143
Adjustments to reconcile net income to net cash provided by operating activities-
Depreciation and amortization	98,507	83,970
Deferred taxes	(28,204)	(46,433)
Reserve for warranty expense	1,500	800
Changes in operating assets and liabilities-
Accounts receivable	(393,467)	(56,932)
Installment receivables	(1,032)	0
Inventories	(175,923)	129,906
Income taxes receivable	154,088	0
Prepaid expenses and other	(48,641)	(42,130)
Deposits and other	(1,336)	2,099
Accounts payable	213,020	94,809
Customer deposits	216	2,091
Accrued expenses	(30,917)	(233,216)
Deferred income	71,994	107,287
Income taxes payable	0	56,697
Net cash provided from operating activities	175,319	351,091
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(21,379)	(67,550)
Purchase of patent	(4,459)	0
Net cash (used in) investing activities	(25,838)	(67,550)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of 10,000 shares of common stock at $1.52 per share	15,200	0
Net cash provided from financing activities	15,200	0
NET INCREASE (DECREASE) IN CASH	164,681	283,541
CASH, BEGINNING OF PERIOD	2,338,012	1,844,802
CASH, END OF PERIOD	2,502,693	2,128,343
Supplemental cash flow disclosure:
Cash paid for income taxes	$ 1,790	$ 133,694

XML

Condensed Balance Sheets (USD $)	Jun. 30, 2013	Dec. 31, 2012
ASSETS
Cash	$ 2,502,693	$ 2,338,012
Accounts receivable, net	798,788	405,321
Installment receivables	1,032	0
Inventories, net	1,008,593	832,670
Income taxes receivable	20,041	174,129
Deferred taxes	153,850	130,172
Prepaid expenses and other	80,170	31,529
Total current assets	4,565,167	3,911,833
PROPERTY AND EQUIPMENT, at cost:
Production equipment	272,075	258,703
Office equipment	149,852	144,202
Sales and marketing equipment	177,701	175,344
Purchased software	46,203	46,203
Less accumulated depreciation	(431,714)	(365,728)
Total property and equipment, net	214,117	258,724
OTHER ASSETS:
Technology licenses, net	23,331	55,139
Patents, net	15,699	11,953
Deferred taxes, long term	6,638	2,112
Deposits and other	56,040	54,704
Total other assets	101,708	123,908
Total assets	4,880,992	4,294,465
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	295,816	82,796
Customer deposits	510	294
Accrued expenses	247,407	278,324
Deferred income, current portion	218,613	158,527
Reserve for warranty expense	24,600	23,100
Total current liabilities	786,946	543,041
DEFERRED INCOME, net of current portion	17,467	5,559
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Common stock, no par value; 50,000,000 shares authorized, 2,432,416 shares outstanding (2,422,416 at December 31, 2012)	4,324,897	4,309,697
Accumulated (deficit)	(248,318)	(563,832)
Total stockholders' equity	4,076,579	3,745,865
Total liabilities and stockholders' equity	$ 4,880,992	$ 4,294,465

XML

6. LINE OF CREDIT (Details Narrative) (USD $)	Jun. 30, 2013
Line Of Credit Details Narrative
Line of Credit Facility	$ 0

XML

8. SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements

NOTE 8 - SUBSEQUENT EVENTS

8.  SUBSEQUENT EVENTS

We evaluated all of our activity and concluded that no subsequent events have occurred that would require recognition in our financial statements or disclosure in the notes to our financial statements.

XML

3. BASIC AND DILUTED INCOME PER COMMON SHARE (Tables)

6 Months Ended

Jun. 30, 2013

Basic And Diluted Income Per Common Share Tables

Basic and diluted net income (loss) per share

	Three Months Ended
	June 30, 2013		June 30, 2012
Net income	$	173,505	$	132,435
Weighted-average shares — basic		2,426,542		2,422,416
Effect of dilutive potential common shares		-		23,000
Weighted-average shares — diluted		2,426,542		2,445,416
Net income per share — basic	$	0.07	$	0.05
Net income per share — diluted	$	0.07	$	0.05
Antidilutive employee stock options		-		-

	Six Months Ended
	June 30, 2013		June 30, 2012
Net income	$	315,514	$	252,143
Weighted-average shares — basic		2,430,537		2,422,416
Effect of dilutive potential common shares		-		23,000
Weighted-average shares — diluted		2,430,537		2,445,416
Net income per share — basic	$	0.13	$	0.10
Net income per share — diluted	$	0.13	$	0.10
Antidilutive employee stock options		-		-

XML

7. COMMITMENTS

6 Months Ended

Jun. 30, 2013

Commitments and Contingencies Disclosure [Abstract]

Note 7. COMMITMENTS

7.  COMMITMENTS

We entered into a development contract in March 2013, which calls for an initial deposit of $31,602, followed by payments totaling $94,804 to be made as work is performed.

XML

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

These financial statements have been prepared by us, without audit, and reflect normal recurring adjustments which, in the opinion of management, are necessary for a fair statement of the results of the second quarter of 2013.  These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with footnotes contained in our financial statements for the year ended December 31, 2012 included in our Form 10-K.

Use of Estimates in the Preparation of Financial Statements.   The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities of the Company as well as disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expense during the reporting period.  Actual results could differ from those estimates.

Note Receivable. We made a loan of $62,500 to Tipping Point, Inc. (“TPI”), an early stage company, during the second quarter of 2011.  Although the loan has been paid down by $27,000, including a repayment of $2,000 in the second quarter of 2013, we do not expect to realize any significant sales to TPI in the near term.  We have provided a reserve against the loan for the full amount, leaving a net amount of $0, which is not included in our balance sheet at June 30, 2013.  This note has a provision entitling us to convert any outstanding balance into stock of TPI.  TPI is considered a related party as certain of our board members were also TPI board members during a portion of 2011.

Inventories.   Inventories are stated at the lower of cost (first-in, first-out basis) or market. We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required.  At June 30, 2013 and December 31, 2012, inventory consisted of the following:

	2013			2012
Raw materials & deposits	$	415,647		$	271,865
Work-in-process		198,140			126,209
Finished goods		451,370			479,596
Total gross inventories		1,065,157			877,670
Less reserve for obsolescence		(56,564	)		(45,000	)
Total net inventories	$	1,008,593		$	832,670

Income Taxes.  We account for income taxes under the provisions of Accounting Standards Codification Topic 740, “Accounting for Income Taxes” (“ASC 740”). We have determined an estimated annual effective tax rate.  The rate will be revised, if necessary, as of the end of each successive interim period during our fiscal year to our best current estimate.

The estimated annual effective tax rate is applied to the year-to-date ordinary income (or loss) at the end of the interim period.

ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  This pronouncement also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

Revenue Recognition.   Revenue from product sales is recorded when we ship the product and title has passed to the customer, provided that we have evidence of a customer arrangement and can conclude that collection is probable.  The prices at which we sell our products are fixed and determinable at the time we accept a customer's order. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims, and generally have no ongoing obligations related to product sales, except for normal warranty.

Deferred revenues arising from installment receivables are recognized as sales when collected.  Service contracts are booked as sales over their life on a straight-line basis; development contracts are considered as sales when they are complete.  Supplies are recognized as sales when they are shipped.  Training revenues are recognized at the time the training occurs.  On occasion we arrange for customer financing and leasing through unrelated third parties.  We recognize as revenue a fee from this arrangement at the time of the transaction.  Occasionally, we rent used breathalyzers to customers, and in those cases, we recognize the revenues as they are earned over the life of the contract. 

Royalty income is recognized in accordance with agreed upon terms, when performance obligations are satisfied, the amount is fixed or determinable and collectability is reasonably assured.

Deferred Revenue.  Deferred revenues arise from installment receivables, from service contracts and from development contracts.   Deferred revenues from installment receivables are recognized as sales when collected, generally over two years.  Revenues from service contracts are recognized on a straight-line basis over the life of the contract, generally one year.  However, there are occasions when they are written for longer terms up to four years.  The revenues from that portion of the contract that extend beyond one year and from that portion of installment receivables that extend beyond one year are shown in our balance sheet as long term.  Deferred revenues also result from progress payments received on development contracts; those revenues are recognized when the contract is complete.  All development contracts are for less than one year and all deferred revenues from this source are shown in our balance sheet as short term.

Fair Value of Financial Instruments.   Our financial instruments consist of cash and cash equivalents, short-term trade receivables, short-term installment receivables, note receivable and payables.  The carrying values of cash and cash equivalents, short-term receivables and payables approximate their fair value due to their short term maturities.

Recent Accounting Pronouncements.  We have reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial condition or the results of our operations.

XML

3. BASIC AND DILUTED INCOME PER COMMON SHARE (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
INCOME PER COMMON SHARE
Net income	$ 173,505	$ 132,435	$ 315,514	$ 252,143
Weighted-average shares - basic	2,426,542	2,422,416	2,430,537	2,422,416
Effect of dilutive potential common shares	0	23,000	0	23,000
Weighted-average shares - diluted	2,426,542	2,445,416	2,430,537	2,445,416
Net income per share - basic	$ 0.07	$ 0.05	$ 0.13	$ 0.1
Net income per share - diluted	$ 0.07	$ 0.05	$ 0.13	$ 0.1
Antidilutive employee stock options	0	0	0	0

XML

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2013

Summary Of Significant Accounting Policies Tables

Inventories

	2013			2012
Raw materials & deposits	$	415,647		$	271,865
Work-in-process		198,140			126,209
Finished goods		451,370			479,596
Total gross inventories		1,065,157			877,670
Less reserve for obsolescence		(56,564	)		(45,000	)
Total net inventories	$	1,008,593		$	832,670

XML

5. RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)	6 Months Ended
	Jun. 30, 2013
Related Party Transactions Details Narrative
Consulting fee to director	$ 15,000

XML

4. STOCKHOLDERS' EQUITY (Details) (USD $)	6 Months Ended
	Jun. 30, 2013
Stockholders Equity Details
Range of Exercise Prices	$ 3.69
Option Outstanding	23,000
Weighted Average Remaining Contractual Life (in Years)	4 years
Weighted Average Exercise Price per Share	$ 3.69
Number Exercisable	23,000
Weighted Average Exercise Price per Share	$ 3.69

XML

Document and Entity Information	6 Months Ended
	Jun. 30, 2013	Aug. 07, 2013
Document And Entity Information
Entity Registrant Name	Lifeloc Technologies, Inc
Entity Central Index Key	0001493137
Document Type	10-Q
Document Period End Date	Jun. 30, 2013
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		2,432,416
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2013

XML

4. STOCKHOLDERS' EQUITY (Details Narrative)	Jun. 30, 2013	Dec. 31, 2012
Stockholders Equity Details Narrative
Common Stock Authorized	50,000,000	50,000,000